NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

I believe you're correct in this assessment. My conversations with NWBO over the past year reflect a consistent message that "there are many ways with which we can win" with this technology. The "ongoing dialogue with regulators" I feel has been a constant lobbying if you will about allowing flexibility in resulting data analysis because of the fast pace of new evidence that is showing that traditional chemo/drug therapy statistical analysis for FDA approval are not effective in presenting the clinical effect of immuno therapy biologics.